EVEROLIMUS

43324 reported adverse events

Drug classes: Kinase Inhibitor [EPC] mTOR Inhibitor Immunosuppressant [EPC]

These side effects are most commonly reported by patients taking EVEROLIMUS:

# Side effect Count
0 DEATH 5877
1 MALIGNANT NEOPLASM PROGRESSION 4074
2 DIARRHOEA 3511
3 FATIGUE 3373
4 STOMATITIS 2937
5 NAUSEA 2431
6 DYSPNOEA 2391
7 PYREXIA 1941
8 DECREASED APPETITE 1877
9 RASH 1807
See all common reactions for EVEROLIMUS

EVEROLIMUS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 78 0.4483
1 ANGIOFIBROMA 26 0.3611
2 INFUSION SITE COLDNESS 23 0.3239
3 PIK3CA-ACTIVATED MUTATION 61 0.2785
4 PANCREATIC NEUROENDOCRINE TUMOUR 120 0.2603
5 BRAIN STEM GLIOMA 27 0.2571
6 POLYOMAVIRUS VIRAEMIA 86 0.2038
7 NEUROENDOCRINE TUMOUR 216 0.1985
8 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 33 0.1964
9 ASTROCYTOMA, LOW GRADE 22 0.1760
See all enriched reactions for EVEROLIMUS